United States · Bill · S
S. 642 (118th)
Finn Sawyer Access to Cancer Testing Act
Introduced
2 March 2023
Last action
2 March 2023 · Introduced
Status
Read twice and referred to the Committee on Finance.
Sponsors
Amy Klobuchar, Roger Wicker
Subjects
Healthcare, Education
Source updated
5 December 2025
Summary
Finn Sawyer Access to Cancer Testing Act This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer. Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
2 March 2023
Introduced
Read twice and referred to the Committee on Finance.
Source: IntroReferral
2 March 2023
Introduced
Introduced in Senate
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 2 March 2023 · Official file
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 2 March 2023
Introduced in Senate (PDF)
Introduced in Senate · EN · 2 March 2023
Introduced in Senate
summary · EN · 2 March 2023
Sponsors
- Amy Klobuchar · D · Sponsor
- Roger Wicker · R · Sponsor
- · ssfi00 · Standing
Related records
- related to ← Finn Sawyer Access to Cancer Testing Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/senate-bill/642
- Open data entity: https://api.congress.gov/v3/bill/118/s/642
- us · 118-s-642 · source updated 5 December 2025